S. 1416: Affordable Prescriptions for Patients Act of 2019
CBO Score
$-440,000,000
Documentation
Date of Report
Fri July 19th, 2019
CBO Report Details
Legislation Details
116th Congress
A bill to amend the Federal Trade Commission Act to prohibit anticompetitive behaviors by drug product manufacturers, and for other purposes.
Sponsor: Sen. John Cornyn — R — TX
Amends the Federal Trade Commission Act to prohibit anticompetitive behaviors by drug product manufacturers, and for other purposes.
JOIN US!
Sign up below to receive updates when your Members of Congress vote for new spending increases or cuts.
Lost your Password?
Don't be sad- we've got your back. Just enter your email below and instructions on resetting your password will be sent to you.
×